What Happened
A former registered nurse from Greene County, New York, was sentenced in Albany federal court to 30 months in prison, followed by three years of supervised release, for unlawfully distributing opioids, defrauding insurance companies, and trying to obstruct the investigation into her conduct.
In her guilty plea, entered September 4, 2019, the nurse admitted that between 2015 and 2017 she worked with a physician to obtain prescriptions for oxycodone, morphine and hydromorphone for no legitimate medical purpose. She did so by impersonating the physician's patients at pharmacies, knowing that health care benefit programs would pay the cost of the drugs. The release describes this as an opioid distribution scheme and says she impersonated patients of the co-conspirator and defrauded insurance companies as part of it.
She also admitted that she tried to obstruct a federal investigation by testifying falsely before a federal grand jury that she was blackmailing the physician into providing the prescriptions. As she admitted in her plea, that was a lie: the physician was not the subject of an extortion scheme and was a willing member of the conspiracy. She admitted that the physician agreed to pay her for the false testimony in the hope of minimizing the physician's criminal exposure and keeping a medical license.
The physician pleaded guilty to conspiring to distribute controlled substances, health care fraud, aggravated identity theft and obstruction of justice, and was sentenced to 54 months in prison earlier in the month the nurse was sentenced. The sentence was imposed by U.S. District Judge Mae A. D’Agostino. The DEA investigated, with assistance from the New York Bureau of Narcotic Enforcement.
“to obtain prescriptions for oxycodone, morphine, and hydromorphone, for no legitimate medical purpose”
What the Release Does Not Say
The release does not name the pharmacies, does not say how many prescriptions were filled or in what quantities, and does not say how the scheme was first detected. It does not say whether any pharmacy employee was aware of the impersonation. The account above is limited to the admissions the release reports.
Where a Dispensing Pharmacy Could See It
The nurse in this case was not diverting from a facility's stock; she was obtaining drugs through the prescription channel, at the point where a pharmacy dispenses to a person who presents as a patient. That channel is covered by the pharmacy's own verification steps, which a pharmacy can examine for itself:
- Verify the identity of the person collecting a controlled substance prescription, and record it. New Jersey's data-reporting rule, for example, requires identifying information for anyone other than the patient who picks up a prescription when the pharmacist reasonably believes the pickup may be for a purpose other than treatment; see the New Jersey page.
- Use the state prescription monitoring database where the law or the pharmacist's judgment calls for it. A pattern of opioid prescriptions from one prescriber for patients who share contact details or payment sources is a reason to ask questions. The New York page summarises that state's rules.
- Review a prescriber's controlled substance volume against the prescriber's practice type, since in this case the prescribing itself had no legitimate medical purpose.
Related Guidance
- New York State Law — Statutes, board rules, penalties and reporting deadlines.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Case Registry — More documented healthcare diversion cases and outcomes.